RareWays is a research directory. It helps you understand the science. It is not medical advice. Always discuss your care options with your healthcare team.
Coverage: 2020-01-01 onwards, with up to 300 results per query from PubMed and Europe PMC and separate limits on other sources. This is a selected index, not a complete literature search.
Your saved research and appointment questionsView recorded trial and retraction changes
Citrullinaemia Type 1: Research Summary
Printed from RareWays (rareways.org)
For general awareness only. Not medical advice. Discuss all care options with your healthcare team.
5 Most Recent Research Articles
- 1.
Hyperkinetic Movements in an Infant with Citrullinemia Type 1
Somdattaa Ray, Annals of Child Neurology (8 September 2026)
https://doi.org/10.26815/acn.2026.01662
- 2.
Sudden Acute Liver Failure in Citrullinemia Type 1: An Argument for Earlier Liver Transplantation?
Eldredge Jessica A et al., The Journal of pediatrics (1 September 2026)
https://pubmed.ncbi.nlm.nih.gov/42235881/
- 3.
Neonatal Citrullinaemia Type I Complicated by Hyperinsulinaemic Hypoglycaemia: Challenges in Managing Dual Metabolic Pathways.
Aras-Col Tugce et al., Journal of paediatrics and child health (8 August 2026)
https://pubmed.ncbi.nlm.nih.gov/42568312/
- 4.
Is mild citrullinemia type I truly benign? a study of long-term clinical outcomes.
İşler-Soylu Elif et al., Journal of pediatric endocrinology & metabolism : JPEM (24 June 2026)
https://pubmed.ncbi.nlm.nih.gov/42190069/
- 5.
Functional profiling of 2,193 ASS1 missense variants: Insights into variant pathogenicity and epistatic interactions in citrullinemia type I.
Lo Russell S et al., PLoS genetics (1 June 2026)
https://pubmed.ncbi.nlm.nih.gov/42308225/
Source: RareWays research directory. Data from PubMed, Europe PMC, OpenAlex, ClinicalTrials.gov.
Always verify information with your healthcare team before making any decisions about your care.
Citrullinaemia Type 1
Citrullinaemia type 1 is a rare inherited urea cycle disorder caused by changes in the ASS1 gene. The body cannot clear ammonia properly, so it builds up in the blood and can harm the brain, often within the first days of life. Care includes a low-protein diet, medicines that help remove ammonia, and an emergency plan for illness. Some people are considered for liver transplant.
This overview is general information, not an individual medical assessment. Research is selected automatically and may include mismatches. How we select and explain research.
Most Recent Research
Citrullinemia type 1 is a rare inborn error of urea cycle metabolism caused by variants in the argininosuccinate synthase 1 (ASS1) gene, resulting in deficiency of the ASS1 enzyme.Affected children typically present shortly after birth with hyperammonemic encephalopathy, vomiting, feeding refusal, stroke-like episodes, and seizures, which may be fatal [1].We report an infant with encephalopathy followed by generalized tremor and chorea who was diagnosed with citrullinemia type 1.A 10-month-old girl presented with global developmental delay, excessive crying, decreased limb movements, and 15 days of vomiting after a febrile episode that followed varicella immunization.She had one seizure episode with postictal drowsiness.She was born to nonconsanguineous parents after an uneventful perinatal period.The child was intubated because of drowsiness, and paucity of limb movements on the left side was noted.Blood tests revealed an ammonia level of 285 µmol/L, abnormal liver function test results, and prolonged prothrombin time and activated partial thromboplastin time.There was no evidence of metabolic acidosis.As a urea cycle defect (UCD) was suspected, peritoneal dialysis was initiated, and sodium benzoate was administered to treat hyperammonemia.After regaining consciousness and extubation, she developed generalized tremor, generalized chorea, and perioral dyskinesia while her plasma ammonia level was 1 www.annchildneurol.org
Common Questions
What is Citrullinaemia Type 1?
Citrullinaemia type 1 is a rare inherited urea cycle disorder caused by changes in the ASS1 gene. The body cannot clear ammonia properly, so it builds up in the blood and can harm the brain, often within the first days of life. Care includes a low-protein diet, medicines that help remove ammonia, and an emergency plan for illness. Some people are considered for liver transplant.
How many clinical trials are available for Citrullinaemia Type 1?
RareWays currently indexes 1 clinical trial for Citrullinaemia Type 1. These counts cover indexed trials across countries, not just your country. An Australian site does not necessarily mean that site is recruiting. Check locations, eligibility and current availability with the study team.
Where does the research data for Citrullinaemia Type 1 come from?
RareWays aggregates research from PubMed, Europe PMC, OpenAlex, and ClinicalTrials.gov. Data is refreshed automatically every day. All articles and trials link directly to their original sources.
Get research updates
Monthly email when new findings are published for Citrullinaemia Type 1.
Your email and selected disease are stored for these updates. Unsubscribe any time. Privacy and deletion.
This information is for general awareness only.
For guidance specific to your situation, please speak with your healthcare team.